Andre Robidoux

Andre Robidoux

UNVERIFIED PROFILE

Are you Andre Robidoux?   Register this Author

Register author
Andre Robidoux

Andre Robidoux

Publications by authors named "Andre Robidoux"

Are you Andre Robidoux?   Register this Author

64Publications

1734Reads

38Profile Views

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

J Clin Oncol 2018 04 14;36(11):1073-1079. Epub 2018 Feb 14.

Irene L. Wapnir, Stanford University School of Medicine, Stanford, CA; Karen N. Price and Shari Gelber, Frontier Science and Technology Research Foundation, Richard D. Gelber, Frontier Science and Technology Research Foundation, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, Meredith M. Regan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Stewart J. Anderson, University of Pittsburgh Graduate School of Public Health; Priya Rastogi, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec; Alexander H.G. Paterson, Tom Baker Cancer Centre, Calgary, Alberta, Canada; Miguel Martín, CIBERONC, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid; José Manuel Baena-Cañada, Hospital Puerta del Mar, Cádiz, Spain; Johan W.R. Nortier, Leids Universitair Medisch Centrum, Leiden, Netherlands; Mothaffar F. Rimawi, Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St. Gallen; Stefan Aebi, Lucerne Cantonal Hospital and University of Bern, Switzerland; Eleftherios P. Mamounas, Orlando Health University of Florida Health Cancer Center, Orlando, FL; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; and Alan S. Coates, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891132PMC
April 2018

Comparative Evaluation of Iodine-125 Radioactive Seed Localization and Wire Localization for Resection of Breast Lesions.

Can Assoc Radiol J 2017 Nov 15;68(4):447-455. Epub 2017 Sep 15.

Breast Imaging Center, Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carj.2017.04.006DOI Listing
November 2017

Limitations of Personalized Medicine and Gene Assays for Breast Cancer.

Cureus 2017 Mar 17;9(3):e1100. Epub 2017 Mar 17.

Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.1100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393908PMC
March 2017

The Added Value of Statistical Modeling of Backscatter Properties in the Management of Breast Lesions at US.

Radiology 2015 Jun 12;275(3):666-74. Epub 2014 Dec 12.

From the Department of Radiology, Breast Imaging Center (I.T., M.E.K.), Department of Surgical Oncology, Breast Care Center (A.R.), and Department of Pathology (L.G.), Centre Hospitalier de l'Université de Montréal, 3840 Saint-Urbain, Montreal, QC, Canada H2W 1T8; Department of Radiology, Radio-Oncology and Nuclear Medicine (I.T., M.E.K., G.C.) and Institute of Biomedical Engineering (G.C.), Université de Montréal, Montreal, Quebec, Canada; and Laboratory of Biorheology and Medical Ultrasonics, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada (F.D., L.A., B.C., G.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.14140318DOI Listing
June 2015

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

J Clin Oncol 2015 Jan 1;33(3):258-64. Epub 2014 Dec 1.

Jean-Francois Boileau, Mark Basik, and Andre Lisbona, Montreal Jewish General Segal Cancer Centre, McGill University; Louis Gaboury, Isabelle Trop, Rami J. Younan, Erica Patocskai, and Andre Robidoux, Centre Hospitalier de l'Universite de Montreal; Lucas Sideris, Hopital Maisonneuve Rosemont, Universite de Montreal; Sarkis Meterissian and Atilla Omeroglu, McGill University Health Centre, Montreal; Brigitte Poirier and Louise Provencher, Hopital Saint-Sacrement, Universite Laval, Quebec City, Quebec; Claire M.B. Holloway and Frances C. Wright, Sunnybrook Odette Cancer Centre, University of Toronto; David R. McCready, University Health Network, University of Toronto, Toronto; Angel Arnaout, Ottawa Hospital, University of Ottawa, Ottawa; Muriel Brackstone, London Regional Cancer Program, University of Western Ontario, London, Ontario, Canada; and Stephen E. Karp, Lahey Hospital and Medical Center, Tufts University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7827DOI Listing
January 2015

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

Breast Cancer Res Treat 2014 Jul 13;146(1):153-62. Epub 2014 Jun 13.

Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa Hospital Research Institute and University of Ottawa, Box 912, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3015-6DOI Listing
July 2014

Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial.

J Clin Oncol 2014 Jul 16;32(21):2231-9. Epub 2014 Jun 16.

Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1517DOI Listing
July 2014

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.

J Clin Oncol 2013 Sep 12;31(26):3197-204. Epub 2013 Aug 12.

Sandra M. Swain, Gong Tang, Charles E. Geyer Jr, Priya Rastogi, James N. Atkins, Paul P. Donnellan, Louis Fehrenbacher, Catherine A. Azar, André Robidoux, Jonathan A. Polikoff, Adam M. Brufsky, David D. Biggs, Edward A. Levine, John L. Zapas, Louise Provencher, Soonmyung Paik, Joseph P. Costantino, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project (NSABP); Norman Wolmark, Allegheny General Hospital, Allegheny Health Network; Gong Tang and Joseph P. Costantino, NSABP Biostatistical Center and University of Pittsburgh Graduate School of Public Health; Priya Rastogi, University of Pittsburgh Cancer Institute; Adam M. Brufsky, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA; James N. Atkins, Southeast Cancer Control Consortium-Community Clinical Oncology Program, Goldsboro; Edward A. Levine, Wake Forest University, Winston-Salem, NC; Paul P. Donnellan, University Hospital, Galway, and the All-Ireland Cooperative Oncology Research Group, Dublin, Ireland; Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo; Jonathan A. Polikoff, Kaiser Permanente Southern California, San Diego, CA; Catherine A. Azar, Kaiser Permanente, Denver, CO; André Robidoux, Centre hopitalier de l'Université de Montréal (CHUM), Montréal; Louise Provencher, CHU de Québec, Hôpital du Saint-Sacrement, Québec City, QC, Canada; David D. Biggs, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE; John L. Zapas, Medstar Franklin Square Medical Center, Baltimore, MD; Donald W. Northfelt, Mayo Clinic Arizona, Scottsdale, AZ; and Eleftherios P. Mamounas, MD Anderson Cancer Center, Orlando, FL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2013/08/12/JCO.2012.48
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.48.1275
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.48.1275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757290PMC
September 2013

Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses.

J Natl Cancer Inst 2013 Feb 24;105(4):280-92. Epub 2013 Jan 24.

Unité de recherche en santé des populations (URESP), Hôpital du Saint-Sacrement, 1050 chemin Sainte-Foy, Québec, QC, Canada, G1S 4L8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs512DOI Listing
February 2013

Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials.

Cancer Treat Rev 2012 Oct 23;38(6):673-88. Epub 2012 Feb 23.

Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.12.002DOI Listing
October 2012

Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer.

J Clin Oncol 2011 Oct 19;29(30):4007-13. Epub 2011 Sep 19.

Centre Hospitalier Affilié Universitaire de Québec, Québec, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.1007DOI Listing
October 2011

In the end what matters most? A review of clinical endpoints in advanced breast cancer.

Oncologist 2011 6;16(1):25-35. Epub 2011 Jan 6.

University of Toronto, Sunnybrook Odette Cancer Centre, T-Wing, 2nd Floor, 2075 Bayview Avenue, Toronto, Ontario, M2N 3E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2010-0278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228053PMC
June 2011

Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.

Expert Rev Anticancer Ther 2010 Nov 30;10(11):1825-36. Epub 2010 Sep 30.

Danish Breast Cancer Cooperative Group, Rigshospitalet, Department of Oncology 2501, Blegdamsvej 9, Kobenhavn O 2100, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.160DOI Listing
November 2010

Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.

Breast Cancer Res Treat 2010 Apr 4;120(3):685-91. Epub 2009 Aug 4.

Unité de recherche en santé des populations, Hôpital du Saint-Sacrement, Centre de recherche du Centre hospitalier affilé universitaire de Québec, 1050 chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0477-zDOI Listing
April 2010

Patterns of confidant use among patients and spouses in the year after breast cancer.

J Cancer Surviv 2009 Dec 25;3(4):202-11. Epub 2009 Sep 25.

Unité de recherche en santé des populations (URESP), Centre de recherche FRSQ du Centre hospitalier affilié universitaire de Québec, Québec, QC, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11764-009-0096-z
Publisher Site
http://dx.doi.org/10.1007/s11764-009-0096-zDOI Listing
December 2009

Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity.

Breast Cancer Res Treat 2009 Sep 23;117(2):417-22. Epub 2009 Jan 23.

Epidemiology Research Unit, Research Centre, Centre hospitalier de l'Université de Montréal Hôtel-Dieu, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0292-yDOI Listing
September 2009

Germline RAP80 mutations and susceptibility to breast cancer.

Breast Cancer Res Treat 2009 Jan 28;113(2):377-81. Epub 2008 Feb 28.

Women's College Research Institute, University of Toronto, 790 Bay Street, 7th floor, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-9938-zDOI Listing
January 2009

Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.

Breast Cancer Res Treat 2008 Apr 31;108(3):399-408. Epub 2007 May 31.

The Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9608-6DOI Listing
April 2008

Wage losses in the year after breast cancer: extent and determinants among Canadian women.

J Natl Cancer Inst 2008 Mar 26;100(5):321-32. Epub 2008 Feb 26.

Unité de recherche en santé des populations, Centre de recherche du Centre Hospitalier Affilié Universitaire de Québec, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djn028DOI Listing
March 2008

Couples who get closer after breast cancer: frequency and predictors in a prospective investigation.

J Clin Oncol 2005 May;23(15):3588-96

Unité de recherche en santé des populations, Centre de recherche du Centre Hospitalier Affilé Universitaire de Quebec, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.628DOI Listing
May 2005